1 study on Oxytocinergic pathway mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**Central MC receptor activation via PT-141 offers a mechanistically distinct alternative to PDE5 inhibitors**, potentially benefiting patients who fail vascular-targeted therapies or who present primarily with reduce…